AstraZeneca, Daiichi’s drug cleared for wider use in breast cancer patients in US
Astra is due to pay Daiichi US$175 million in milestones after the US approval, the companies said. Enhertu is cleared in the ...
Citizen Scientists Reclaim Japan’s Nuclear Disaster Zone
Armed with measuring devices, groups of citizens are embracing science to monitor radioactive fallout — and regain control of ...
ジャパンタイムズ10d
Daiichi Sankyo rises most in five months on cancer drug approval
Drugmaker Daiichi Sankyo has risen the most in five months after its novel breast cancer treatment won U.S. approval, a ...
AstraZeneca's and Daiichi Sankyo's Enhertu wins new approval in US
The Cambridge, England-based and Tokyo-based pharmaceutical companies said the US Food & Drug Administration approved Enhertu for the treatment of adult patients with unresectable or metastatic ...
Daily10d
AstraZeneca-Daiichi Sankyo Datroway gets USFDA nod for previously treated Metastatic HR Positive, HER2 Negative Breast Cancer
Tokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the ...
Ichiro is about to get his Hall of Fame moment. For Japan, he's more than just a baseball star
Ichiro will go into the Hall of Fame as professional baseball’s all-time leader in hits with 4,367 (3,089 in MLB and 1,278 in ...
朝日新聞社1d
VOX POPULI: Charming traditional soundscapes fill the chilly air
In the past, “kamisuki,” or the traditional craft of making paper by hand, was a thriving industry in the neighborhood of Asakusa, Tokyo ... due to “Tori no Ichi” (rooster market ...
Business Wire16d
Daiichi Sankyo Acquires Intellectual Property Rights for Anti-TA-MUC1 Antibody in DS-3939 from Glycotope GmbH
Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual ...